Pharmacy Pearls for Prescribers- Asthma

Instructions to Receive Credit

Thursday, July 29, 2021, 8:00 AM - Saturday, December 31, 2022, 5:30 PM

Pharmacy Pearls for Prescribers provides up-to-date information on medications, developed by a multidisciplinary group of AMG primary care physicians and pharmacists from Avera Health and Avera Health Insurance Division. An interdisciplinary group has been working to develop educational materials to meet this need. In this series we will discuss asthma care related to: asthma guideline updates, overview of available agents for asthma treatment, asthma checklist prior to initiating biologics and outpatient management of outpatient exacerbations in adults.

Avera is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Avera designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Avera is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. A total 1.00 contact hours can be received upon completion of this activity.  This activity has been approved for 1.0 pharmacotherapeutic credits.

1. Review updated asthma guidelines
2. Identify available agents for asthma treatment
3. Define steps needed prior to initiating biologics
4. Discuss outpatient treatment of asthma exacerbations in adults

There is no cost for this educational activity.

 

---

© 2021 Avera Health, All Rights Reserved

 

 

Mitigation of Relevant Financial Relationships

Avera adheres to the Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control or influence the content of a CE activity, including but not limited to faculty, planners, authors, and reviewers are required to disclose all relevant financial relationships with an ineligible companies. All relevant financial relationships have been mitigated.